http://www.marketwatch.com/story/novavax-announces-positive-top-line-data-from-dose-confirmatory-phase-2-clinical-trial-of-its-rsv-vaccine-candidate-in-women-of-childbearing-age-2014-04-28?reflink=MW_news_stmp
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment